BLATT LAWRENCE
Insider CIK 1242110 · ALGS President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2026-03-09 | 2026-03-11 | 105,840 | — | $0 | 105,840 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-07-16 | 2025-07-18 | 179,800 | — | $0 | 179,800 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2025-02-28 | 2025-03-04 | 140,103 | — | $0 | 140,103 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-09-04 | 2024-09-06 | 33,920 | — | $0 | 33,920 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 965,435 | — | $0 | 965,435 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 57,749 | — | $0 | 57,749 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 230,999 | — | $0 | 230,999 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2024-02-28 | 2024-02-28 | 132,352 | — | $0 | 132,352 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 80,850 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 450,000 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | D To issuer deriv | 2024-02-27 | 2024-02-28 | 323,400 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-10-25 | 2023-10-27 | 305,138 | $0.13 | $39.7K | 305,138 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award | 2023-10-25 | 2023-10-27 | 610,277 | $0.76 | $463.8K | 1,847,575 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-09-08 | 2023-09-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-17 | 242,500 | — | $0 | 242,500 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-07-07 | 2022-07-11 | 161,700 | — | $0 | 161,700 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 80,850 | — | $0 | 80,850 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 323,400 | — | $0 | 323,400 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | A Award deriv | 2020-12-01 | 2020-12-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 122,601 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 41,016 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 50,712 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 21,695 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 0 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 41,016 | — | $0 | 41,016 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 50,712 | — | $0 | 91,728 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 13,671 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 13,671 | — | $0 | 13,671 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 122,601 | — | $0 | 122,601 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 17,065 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 18,517 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 3,394 | — | $0 | 17,065 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 21,695 | — | $0 | 113,423 | SEC↗ |
| ALGS Aligos Therapeutics, Inc. | C Conversion | 2020-10-20 | 2020-10-20 | 1,452 | — | $0 | 18,517 | SEC↗ |